Research has shown that glycine acts as a signaling molecule in the gut, stimulating specialized L-cells to produce and release GLP-1 and glucagon
If you are comparing your options across the full GLP-1 landscape, the semaglutide vs tirzepatide comparison provides context for both injectable and oral formats
Weeks 1 to 4: 20 units (0.2 mL) once weekly Weeks 5 to 8: 40 units (0.4 mL) once weekly Weeks 9 to 12: 70 units (0.7 mL) once weekly Weeks 13 to 16: 90 units (0.9 mL) once weekly These are unit measurements based on insulin syringe markings
Oral GLP-1 supplements using ingredients like berberine, Reducose, and omega-3 fatty acids have a stronger evidence base, built on oral delivery
Because of the retrospective nature of the study and the use of de-identified data, this study received an exemption waiver for approval and informed consent from the Institutional Review Board (IRB) of Chung Shan Medical University Hospital, identified by the reference number CS1-24047
[Study abstract] Increase the interval between doses: Another option is to increase the interval between doses to greater than one week
